
Please try another search
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Name | Age | Since | Title |
---|---|---|---|
David St. Denis | 56 | 2017 | President & Director |
Wayne Geoffrey Paterson | 58 | 2014 | Vice Chairman & CEO |
Chris Meduri | - | 2021 | Chief Medical Officer & Member of Medical Advisory Board |
Stephen Anthony Denaro | 63 | 2018 | Non-Executive Director & Company Secretary |
David B. Roberts | 61 | 2025 | Director |
Vinayak Bapat | - | - | Member of Global TAVR Medical Advisory Board |
Dion Stub | - | 2022 | Member of Medical Advisory Board |
Karl Poon | - | 2022 | Member of Medical Advisory Board |
Gregory S. Moss | 41 | 2025 | Director |
Bernard Prendergast | - | 2020 | TAVR Medical Advisory Board |
Paul Sorajja | - | - | Member of Medical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review